PCI BIOTECH HOLDING

PCIB

3,02 NOK
-0,22 ( 6,80%)
  • Tid15:30
  • Markedsverdi112,54 mill.
  • Kjøp2,90
  • Selg3,10
  • Høy3,23
  • Lav2,92
  • Volum502 373,00
  • Omsetning1,54 mill.
Dag
Uke
Mnd
YTD
År
3 år
5 år
10 år
Ordredybde
VolumKjøp SelgVolum
20 0002,90
3,1020 500
5002,75
3,471 500
2752,60
3,50500
5002,55
3,853 500
5 8162,40
3,951 500
Børsmeldinger
20. jan 202311:37
Flaggemelding relatert til PCIB
20. jan 202309:13
Flagging 
25. nov 202217:08
PCI Biotech: Employee share option scheme
23. nov 202215:13
Financial calendar 
23. nov 202206:00
PCI Biotech interim Q3 2022 report
17. nov 202216:42
PCI Biotech: Invitation to Q3 2022 results presentation
08. sep 202209:58
Correction: PCI Biotech: Mandatory notification regarding trade of shares
NøkkeltallLevert av FactSet, oppdatert 27. jan.
Volatilitet
3 MÅNEDER
1,35
Beta
1 ÅR
1,24
Kursmål
MEDIAN
4,00
Finanskalender
DatoHendelse
16. febKvartalsrapport - Q4
27. aprÅrsrapport
11. maiKvartalsrapport - Q1
24. maiOrdinær generalforsamling
30. augHalvårsrapport
21. novKvartalsrapport - Q3
Om selskapet
PCI Biotech Holding ASA logo
PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. The company is applied to three distinct anticancer paradigms: fimaCHEM (enhancement of chemotherapeutics for localised treatment of cancer), fimaVACC (T-cell induction technology for therapeutic vaccination), and fimaNAc (nucleic acid therapeutics delivery).
PCI Biotech Holding ASA
PCIB
4767115400
Organisasjonummer
991036393
ISIN
NO0010405640
Innsidere
NavnStilling
Hilde Furberg
Christina Herder
Andrew Mark Hughes
Anders HøgsetCSO
Lars Viksmoen
Største eiere
EierAndel
FONDSAVANSE AS
10,48%
MP PENSJON PK
5,86%
MYRLID AS
5,45%
RADFORSK INVESTERINGSSTIFTELSE
2,90%
GRESSLIEN ODD ROAR
2,54%
NORDNET BANK AB
2,17%
CLEARSTREAM BANKING S.A.
1,35%
RAVI INVESTERING AS
1,34%
JANDERSEN KAPITAL AS
1,26%
BNP PARIBAS
1,15%
Andre
65,52%